Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Sexually Transmitted Diseases

  Free Subscription


Articles published in Br J Cancer

Retrieve available abstracts of 19 articles:
HTML format



Single Articles


    March 2022
  1. REBOLJ M, Pesola F, Mathews C, Mesher D, et al
    The impact of catch-up bivalent human papillomavirus vaccination on cervical screening outcomes: an observational study from the English HPV primary screening pilot.
    Br J Cancer. 2022 Mar 26. pii: 10.1038/s41416-022-01791.
    PubMed     Abstract available


    November 2021
  2. DICK S, Vink FJ, Heideman DAM, Lissenberg-Witte BI, et al
    Risk-stratification of HPV-positive women with low-grade cytology by FAM19A4/miR124-2 methylation and HPV genotyping.
    Br J Cancer. 2021 Nov 6. pii: 10.1038/s41416-021-01614.
    PubMed     Abstract available


    October 2021
  3. MANLEY K, Patel A, Pawade J, Glew S, et al
    The use of biomarkers and HPV genotyping to improve diagnostic accuracy in women with a transformation zone type 3.
    Br J Cancer. 2021 Oct 29. pii: 10.1038/s41416-021-01539.
    PubMed     Abstract available


    September 2021
  4. IDEN M, Tsaih SW, Huang YW, Liu P, et al
    Multi-omics mapping of human papillomavirus integration sites illuminates novel cervical cancer target genes.
    Br J Cancer. 2021 Sep 15. pii: 10.1038/s41416-021-01545.
    PubMed     Abstract available


    June 2021
  5. WAGNER S, Prigge ES, Wuerdemann N, Reder H, et al
    Correction: Evaluation of p16(INK4a) expression as a single marker to select patients with HPV-driven oropharyngeal cancers for treatment de-escalation.
    Br J Cancer. 2021 Jun 10. pii: 10.1038/s41416-021-01457.
    PubMed    


    March 2021
  6. OLIVA M, Schneeberger PHH, Rey V, Cho M, et al
    Transitions in oral and gut microbiome of HPV+ oropharyngeal squamous cell carcinoma following definitive chemoradiotherapy (ROMA LA-OPSCC study).
    Br J Cancer. 2021 Mar 10. pii: 10.1038/s41416-020-01253.
    PubMed     Abstract available


  7. EINBOND LS, Zhou J, Wu HA, Mbazor E, et al
    A novel cancer preventative botanical mixture, TriCurin, inhibits viral transcripts and the growth of W12 cervical cells harbouring extrachromosomal or integrated HPV16 DNA.
    Br J Cancer. 2021;124:901-913.
    PubMed     Abstract available


    December 2020
  8. PATEL U, Pandey M, Kannan S, Samant TA, et al
    Prognostic and predictive significance of nuclear HIF1alpha expression in locally advanced HNSCC patients treated with chemoradiation with or without nimotuzumab.
    Br J Cancer. 2020;123:1757-1766.
    PubMed     Abstract available


    November 2020
  9. KAMAL M, Lameiras S, Deloger M, Morel A, et al
    Human papilloma virus (HPV) integration signature in Cervical Cancer: identification of MACROD2 gene as HPV hot spot integration site.
    Br J Cancer. 2020 Nov 16. pii: 10.1038/s41416-020-01153.
    PubMed     Abstract available


    October 2020
  10. ARROYO MUHR LS, Lagheden C, Lei J, Eklund C, et al
    Deep sequencing detects human papillomavirus (HPV) in cervical cancers negative for HPV by PCR.
    Br J Cancer. 2020 Oct 6. pii: 10.1038/s41416-020-01111.
    PubMed     Abstract available


    July 2020
  11. WAGNER S, Prigge ES, Wuerdemann N, Reder H, et al
    Evaluation of p16(INK4a) expression as a single marker to select patients with HPV-driven oropharyngeal cancers for treatment de-escalation.
    Br J Cancer. 2020 Jul 6. pii: 10.1038/s41416-020-0964.
    PubMed     Abstract available


  12. XU K, Fu Y, Han Y, Xia R, et al
    Fewer tumour-specific PD-1(+)CD8(+) TILs in high-risk "Infiltrating" HPV(-) HNSCC.
    Br J Cancer. 2020 Jul 3. pii: 10.1038/s41416-020-0966.
    PubMed     Abstract available


    June 2020
  13. BAYSAL H, De Pauw I, Zaryouh H, De Waele J, et al
    Cetuximab-induced natural killer cell cytotoxicity in head and neck squamous cell carcinoma cell lines: investigation of the role of cetuximab sensitivity and HPV status.
    Br J Cancer. 2020 Jun 16. pii: 10.1038/s41416-020-0934.
    PubMed     Abstract available


    May 2020
  14. LEI J, Ploner A, Lehtinen M, Sparen P, et al
    Impact of HPV vaccination on cervical screening performance: a population-based cohort study.
    Br J Cancer. 2020 May 4. pii: 10.1038/s41416-020-0850.
    PubMed     Abstract available


    April 2020
  15. ARBYN M, Rezhake R, Yuill S, Canfell K, et al
    Triage of HPV-positive women in Norway using cytology, HPV16/18 genotyping and HPV persistence.
    Br J Cancer. 2020 Apr 3. pii: 10.1038/s41416-020-0787.
    PubMed     Abstract available


  16. HASHIM D, Engesaeter B, Baadstrand Skare G, Castle PE, et al
    Real-world data on cervical cancer risk stratification by cytology and HPV genotype to inform the management of HPV-positive women in routine cervical screening.
    Br J Cancer. 2020 Apr 3. pii: 10.1038/s41416-020-0790.
    PubMed     Abstract available


    November 2019
  17. SABATINI ME, Chiocca S
    Human papillomavirus as a driver of head and neck cancers.
    Br J Cancer. 2019 Nov 11. pii: 10.1038/s41416-019-0602.
    PubMed     Abstract available


    March 2019
  18. FORTNER RT, Terry KL, Bender N, Brenner N, et al
    Sexually transmitted infections and risk of epithelial ovarian cancer: results from the Nurses' Health Studies.
    Br J Cancer. 2019 Mar 21. pii: 10.1038/s41416-019-0422.
    PubMed     Abstract available


    February 2019
  19. CITRO S, Bellini A, Miccolo C, Ghiani L, et al
    Synergistic antitumour activity of HDAC inhibitor SAHA and EGFR inhibitor gefitinib in head and neck cancer: a key role for DeltaNp63alpha.
    Br J Cancer. 2019 Feb 15. pii: 10.1038/s41416-019-0394.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Sexually Transmitted Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: